Hereditary spastic paraplegias (HSP) are a heterogeneous group of genetic diseases (> 80 loci have been described) characterized by the hallmark of progressive lower limb spasticity 1, 2 . Hereditary spastic paraplegias are usually classified on clinical grounds into pure forms, in which only a pyramidal syndrome is found (changes in vibratory sensation and neurogenic bladder are also accepted); and complicated forms, in which the pyramidal syndrome is accompanied by dysfunction in other neurological systems or by systemic involvement 3 . Spastic paraplegia type 4 (SPG4) is the most frequent autosomal dominant, and SPG11 and SPG7 are the most frequent autosomal recessive subtypes worldwide 4, 5 .
One of the most worrisome symptoms faced by patients with neurodegenerative diseases is oropharyngeal dysphagia. Dysphagia is a swallowing disorder that modifies the process of transporting food safely and efficiently from mouth to pharynx and esophagus. Dysphagia can lead to aspiration, malnutrition, dehydration and pneumonia, all of which have a significant impact on the quality of life of patients 6, 7 . A comprehensive description of the clinical evaluation of swallowing in the different forms of HSP is lacking in the literature, where only a few reports of dysphagia frequencies, especially in complicated HSP, were reported 8,9 . Thus, the objective of this study was to verify the prevalence of swallowing disorder and to characterize the main clinical signs of dysphagia in genetically-confirmed HSP patients.
METHODS

Design and subjects
This was a two-center, exploratory, cross-sectional, prevalence study conducted at two teaching hospitals in the Brazilian cities of Porto Alegre and Campinas. The study included consecutive patients followed at the neurogenetics outpatient clinics of these hospitals, from December 2016 to August 2018, who had a genetically-confirmed diagnosis of HSP 5 . Other neurological or systemic conditions that could manifest dysphagia were excluded. The project was approved by the institutions' ethics committees, following the Declaration of Helsinki. Informed written consent was obtained from all individuals prior to participation.
Clinical evaluation of dysphagia
The clinical evaluation of dysphagia was performed, using the Northwestern Dysphagia Patient Check Sheet 10 , by a speech therapist (LAJS) trained in the protocol. The check sheet comprises a brief clinical and functional evaluation of swallowing consisting of 28 items, divided into three steps: medical history and behavioral variables, gross motor function, and an oral motor test. Liquid (100 mL of water), solid (one water cracker), and pasty (45 g yogurt cup) food were used for the functional evaluation of swallowing, which was then labeled as normal, functional swallowing, mild oropharyngeal dysphagia, mild to moderate oropharyngeal dysphagia, moderate oropharyngeal dysphagia, moderate to severe oropharyngeal dysphagia and severe oropharyngeal dysphagia, classified by the protocol of speech-language assessment of risk for dysphagia 11 . In addition, the functionality of oral intake was verified through the Functional Oral Intake Scale 12 . This scale ranges from zero to seven, with a score of zero meaning nothing by mouth, and a score of seven meaning total oral diet with no restriction.
We also applied two self-assessment instruments: the Swallowing Disturbance Questionnaire, which comprises 15 items about swallowing-related changes, where scores ≥ 11 indicate a risk for dysphagia 13 ; and the Eat Assessment Tool-10, which evaluates the emotional impact and physical symptoms that swallowing problems may have on the individual's life. Its score ranges from 0 to 40, with scores > 3 indicating a risk of oropharyngeal dysphagia 14 . We decided to use two different screening protocols for swallowing considering that these instruments may have differing sensitivity to identifying the risk of dysphagia in HSP patients, similar to that seen in other neurological diseases 15 .
Neurological evaluation
Neurological severity was assessed by the Brazilian Portuguese version of the Spastic Paraplegia Rating Scale (range: 0-52, increasing in severity) 16 . We also estimated the cross-sectional disease progression as the cross-sectional quotient of disease severity and disease duration, as previously established 2 . Disease duration and age at onset of the first motor symptom were reported by patients and their relatives.
Data analysis
A descriptive analysis of the results obtained in the Northwestern Dysphagia Patient Check Sheet, Functional Oral Intake Scale and Eat Assessment Tool-10 was carried out in order to characterize the most prevalent findings of dysphagia for each form of HSP.
RESULTS
A total of 54 patients with HSP were enrolled in the study, including 36 SPG4 (17 families), 5 SPG11 (4 families), 4 SPG5 (1 family), 4 CTX (4 families), 3 SPG7 (3 families) and 2 SPG3A (1 family) patients. Table 1 shows the clinical and demographic characteristics of the patients.
Regarding the clinical evaluation of swallowing, 3/5 (60%) and 2/4 (50%) of SPG11 and CTX patients, respectively, presented with mild to moderate oropharyngeal dysphagia, which was the most serious clinical finding of this study. The prevalence of dysphagia in the other groups was much lower, with the majority of patients being diagnosed with normal or functional swallowing. Dysphagia prevalence and description of clinical signs for each HSP form are described in Table 2 . We intended to correlate swallowing performance in SPG4 with independent variables (age, disease duration and severity). However, due to the presence of dysphagia in only a single patient, this analysis was not possible.
DISCUSSION
The clinical evaluation of swallowing includes the collection of information regarding swallowing difficulties, structural and functional analysis of responsible structures, and observation of patients during swallowing attempts 17 . To the best of our knowledge, no previous study has focused on dysphagia characterization in HSPs.
In the present sample, 60% and 50% of patients with SPG11 and CTX, respectively, had mild to moderate oropharyngeal dysphagia, characterized by changes in the oral phase (increased oral transit time and food residue in the oral cavity for the solid consistency) and pharyngeal phase (multiple swallowing for all consistencies and cough for liquids) of swallowing. Regarding feeding functionality, all patients had a total oral diet with more than one consistency, but with the need for special preparation or compensation for most of them. Previous studies have described dysphagia prevalence from 5.7-54% in SPG11 2, 8, 9 ; however, there was neither a description of the evaluation protocol nor the specific results of these alterations. In our study, most SPG11 and CTX patients (5/9) had alterations in the mobility and tonicity of phonoarticulatory organs, in addition to the reduction of the gag reflex, which may increase the risk of laryngotracheal aspiration of saliva and food in these patients. It is important to note that, although we found significant changes in the clinical evaluation protocol, the alterations were not reported by patients. Only a single individual with SPG11 reached the cut-off point indicative of risk for dysphagia in the Eat Assessment Tool-10 and Swallowing Disturbance Questionnaire; however, the validity of these tests in the context of dementia (5/5 patients with SPG11 and 2/4 with CTX met criteria for dementia in our study; data not shown) is limited and, therefore, we do not know if these patients did not have complaints related to swallowing or if they just could not reliably answer the questions.
Regarding the other evaluated HSP subtypes, we found only a single SPG4 (2%) and a single SPG7 patient (33%) with mild oropharyngeal dysphagia. All other patients had normal or functional swallowing with no signs of aspiration risk on the Functional Oral Intake Scale. The low prevalence of dysphagia in the pure forms of HSP that we found is even lower than the 5-5.7% prevalence reported for SPG4 patients in previous studies based on the physician's description 2, 8 . It should be emphasized that the single patient we have described, with SPG4 and mild dysphagia, was a 54-year-old woman with 33 years of illness who was currently wheelchair bound. This information regarding the absence of clinically perceptible changes in swallowing, even in advanced stages of pure forms of HSP, is also important for the differential diagnosis of degenerative conditions that predominantly affect the corticospinal tract, such as primary lateral sclerosis, in which dysphagia is frequent and may be an early symptom 18 .
A limitation of our study was the lack of an objective evaluation of swallowing, which prevented us from evaluating the presence of silent or subclinical aspirations. However, the dysphagia scales used in this study are well-validated and widely-used instruments that are easy to perform with low related costs 10, 11, 12, 13, 14 , giving adequate outcomes to answer the study question on the clinical characterization of oropharyngeal dysphagia in patients with HSP.
In conclusion, patients with predominantly pure forms of HSP (SPG4, SPG5 and SPG3A) have a small risk of oropharyngeal dysphagia, unlike patients with severe complicated forms such as SPG11 and CTX, where this possibility is increased, resulting in a higher risk of laryngotracheal penetration/aspiration. In this sense, the evaluation of swallowing should be performed periodically in patients with complicated forms of HSP, as part of the multidisciplinary care necessary for the adequate treatment of these patients.
